Search

Your search keyword '"Varela L"' showing total 702 results

Search Constraints

Start Over You searched for: Author "Varela L" Remove constraint Author: "Varela L"
702 results on '"Varela L"'

Search Results

1. Fiducial-Cosmology-dependent systematics for the DESI 2024 BAO Analysis

2. Systematic Effects in Galaxy-Galaxy Lensing with DESI

3. HOD-Dependent Systematics in Emission Line Galaxies for the DESI 2024 BAO analysis

4. HOD-Dependent Systematics for Luminous Red Galaxies in the DESI 2024 BAO Analysis

5. Semi-analytical covariance matrices for two-point correlation function for DESI 2024 data

6. DESI 2024 VI: Cosmological Constraints from the Measurements of Baryon Acoustic Oscillations

7. DESI 2024 IV: Baryon Acoustic Oscillations from the Lyman Alpha Forest

8. Optimal Reconstruction of Baryon Acoustic Oscillations for DESI 2024

9. DESI 2024 III: Baryon Acoustic Oscillations from Galaxies and Quasars

10. Modeling the Temperature-Dependent Material Dispersion of Imidazolium-Based Ionic Liquids in the VIS-NIR

11. Non-additive electronic polarizabilities of ionic liquids: Charge delocalization effects

13. The Early Data Release of the Dark Energy Spectroscopic Instrument

14. Validation of the Scientific Program for the Dark Energy Spectroscopic Instrument

15. The catalog-to-cosmology framework for weak lensing and galaxy clustering for LSST

16. Surgical Treatment for Floating Right Heart Thrombus in High Risk Patients

20. POS1368 GENDER AS A KEY FACTOR OF DELAY IN PRESCRIBING THE FIRST BIOLOGIC OR TARGETED SYNTHETIC DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS. DATA FROM BIOBADASER 3.0 REGISTRY

25. Current real-world evidence of genetic testing diagnostic yield in a large cohort of long QT syndrome

26. Contribution of clinically relevant copy number variations in long QT syndrome: a large cohort study

28. Area-Wide Eradication of the Invasive European Grapevine Moth Lobesia botrana in California, USA

29. Founder effect of a pathogenic TNNT2 variant in the northwest of Spain responsible for a non-severe phenotype of hypertrophic cardiomyopathy

30. Contribution of copy number variants to the genetic etiology of dilated cardiomyopathy

31. Meteorin-like plasma levels as a novel biomarker for heart failure

32. Genotipe-phenotype correlation in alpk3 null variants. an extended analysis

33. Microcanonical equations for the Tsallis entropy

34. Non-equilibrium nanothermodynamics

35. POS0281 SAFETY OF BIOSIMILARS THERAPIES FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE SPANISH REGISTRY OF ADVERSE EVENTS WITH BIOLOGIC THERAPIES (BIOBADASER)

36. AB0202 CHARACTERISTICS OF PATIENTS WITH DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS IN REAL LIFE: DATA FROM THE BIOBADASER REGISTRY

37. POS0638 SURVIVAL OF BIOSIMILAR ANTI-TNFΑ BLOCKERS COMPARED TO ORIGINATOR MOLECULES IN RHEUMATOLOGY: RESULTS FROM THE BIOBADASER COHORT

38. POS0249 SEX DIFFERENCES IN PATIENT-REPORTED OUTCOMES IN AXIAL SPONDYLOARTHRITIS PATIENTS TREATED WITH TUMOR NECROSIS FACTOR INHIBITORS: RESULTS FROM A MULTINATIONAL OBSERVATIONAL COHORT STUDY

39. POS1073 IMPACT OF COMORBIDITIES ON THE FIRST BDMARD EFFECTIVENESS AND RETENTION RATE AFTER 2 YEARS OF FOLLOW-UP IN PATIENTS WITH RHEUMATOID ARTHRITIS. DATA FROM THE SPANISH REGISTRY BIOBADASER

42. A Model for B2B Supplier Selection

43. Empagliflozin treatment differentially modifies visceral and subcutaneous adipose tissue lipidomes and pro-inflammatory cytokines in zucker fatty diabetic rats

44. Narrowing Beta-myosin hot spots in its association with hypertrophic cardiomyopathy

47. Rehabilitation after Minimally Invasive Surgery

50. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

Catalog

Books, media, physical & digital resources